Markets
3.23% percent quarterly performance for Nebius Group N.V (NBIS) is not indicative of the underlying story
A new trading day began on Tuesday, with Nebius Group N.V (NASDAQ: NBIS) stock price down -3.91% from the previous ...
$581.12K in average volume shows that Regenxbio Inc (RGNX) is heading in the right direction
On Tuesday, Regenxbio Inc (NASDAQ: RGNX) opened lower -3.93% from the last session, before settling in for the closing price ...
A major move is in the offing as SLM Corp (SLM) market cap hits 5.33 billion
On Tuesday, SLM Corp (NASDAQ: SLM) was -14.96% drop from the session before settling in for the closing price of ...
Revolution Medicines Inc (RVMD) average volume reaches $2.28M: Is Wall Street expecting a rally?
Revolution Medicines Inc (NASDAQ: RVMD) kicked off on Tuesday, down -2.81% from the previous trading day, before settling in for ...
Jazz Pharmaceuticals plc (JAZZ) is expecting 27.86% growth in the next quarter: What can investors do to maximize their returns?
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on Tuesday, plunged -3.95% from the previous trading day, before settling in for the closing ...
A look at Kinder Morgan Inc’s (KMI) recent performance gives investors their first glimpse of hope.
A new trading day began on Tuesday, with Kinder Morgan Inc (NYSE: KMI) stock price up 0.11% from the previous ...
PDS Biotechnology Corporation (PDSB) 20 Days SMA touches 27.08%: The odds favor the bear
On Tuesday, PDS Biotechnology Corporation (NASDAQ: PDSB) opened higher 18.00% from the last session, before settling in for the closing ...
Vistagen Therapeutics Inc (VTGN) is gearing up for another turning point as it hit the volume of 0.76 million
On Tuesday, Vistagen Therapeutics Inc (NASDAQ: VTGN) was 6.06% up from the session before settling in for the closing price ...
$5.03M in average volume shows that Replimune Group Inc (REPL) is heading in the right direction
Replimune Group Inc (NASDAQ: REPL) kicked off on Tuesday, down -4.01% from the previous trading day, before settling in for ...
-33.07% percent quarterly performance for Cognition Therapeutics Inc (CGTX) is not indicative of the underlying story
Cognition Therapeutics Inc (NASDAQ: CGTX) on Tuesday, plunged -4.00% from the previous trading day, before settling in for the closing ...
